1. Home
  2. TPVG vs PRQR Comparison

TPVG vs PRQR Comparison

Compare TPVG & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriplePoint Venture Growth BDC Corp.

TPVG

TriplePoint Venture Growth BDC Corp.

HOLD

Current Price

$5.23

Market Cap

182.2M

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.56

Market Cap

167.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPVG
PRQR
Founded
2013
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.2M
167.5M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
TPVG
PRQR
Price
$5.23
$1.56
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$5.90
$6.80
AVG Volume (30 Days)
430.7K
726.9K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
17.80%
N/A
EPS Growth
N/A
N/A
EPS
1.05
N/A
Revenue
N/A
N/A
Revenue This Year
$7.67
N/A
Revenue Next Year
N/A
$13.92
P/E Ratio
$4.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.48
$1.33
52 Week High
$7.53
$3.10

Technical Indicators

Market Signals
Indicator
TPVG
PRQR
Relative Strength Index (RSI) 49.70 41.52
Support Level $5.03 $1.34
Resistance Level $5.39 $1.58
Average True Range (ATR) 0.18 0.17
MACD 0.02 -0.04
Stochastic Oscillator 38.31 4.67

Price Performance

Historical Comparison
TPVG
PRQR

About TPVG TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the firm's operations are located across the United States.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: